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Abstract
Binary toxins are among the most potent bacterial protein toxins performing a cooperative mode of translocation and
exhibit fatal enzymatic activities in eukaryotic cells. Anthrax and C2 toxin are the most prominent examples for the AB7/8
type of toxins. The B subunits bind both host cell receptors and the enzymatic A polypeptides to trigger their internalization
and translocation into the host cell cytosol. C2 toxin is composed of an actin ADP-ribosyltransferase (C2I) and C2II binding
subunits. Anthrax toxin is composed of adenylate cyclase (EF) and MAPKK protease (LF) enzymatic components associated
to protective antigen (PA) binding subunit. The binding and translocation components anthrax protective antigen (PA63)
and C2II of C2 toxin share a sequence homology of about 35%, suggesting that they might substitute for each other. Here
we show by conducting in vitro measurements that PA63 binds C2I and that C2II can bind both EF and LF. Anthrax edema
factor (EF) and lethal factor (LF) have higher affinities to bind to channels formed by C2II than C2 toxin’s C2I binds to anthrax
protective antigen (PA63). Furthermore, we could demonstrate that PA in high concentration has the ability to transport the
enzymatic moiety C2I into target cells, causing actin modification and cell rounding. In contrast, C2II does not show
significant capacity to promote cell intoxication by EF and LF. Together, our data unveiled the remarkable flexibility of PA in
promoting C2I heterologous polypeptide translocation into cells.
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Introduction
Binary toxins of the AB7/8 type are highly potent and
specialized bacterial protein toxins and are organized in two
different polypeptide chains that are separately secreted in the
external media of Gram-positive bacteria [1]. Component A is
responsible for the intracellular enzymatic activity of the toxin,
whereas heptamers or octamers, of the component B are necessary
for receptor-binding and translocation of component A into target
cells. Given the close homology of structure of the binding
components of these two-component toxins it is of importance to
decipher whether each component can functionally substitute for
each other to intoxicate cells, that we termed cross-reactivity.
One of the most prominent toxins of this type of toxin is anthrax
toxin from Bacillus anthracis [2]. This toxin possesses a binding and
translocation component, protective antigen (PA) and two
enzymatic subunits, edema factor (EF) and lethal factor (LF).
Edema factor (EF) is an 89 kilo Dalton Ca2+- and calmodulin-
dependent adenylate cyclase which catalyzes the production of
intracellular cAMP and causes severe edema. Lethal factor (LF) is
a 90 kilo Dalton Zn2+-binding metalloprotease that cleaves
mitogen-activated protein kinase kinases (MAPK-kinases) and
thereby interferes with the MAPK cascade, a major signaling
pathway, triggered by surface receptors, controlling cell prolifer-
ation and survival [3,4,5]. The binding component PA is essential
for delivery of both enzymes into the target cells [3,6,7]. It is
secreted as an 83 kilo Dalton water-soluble precursor form (PA83)
and needs to undergo proteolytic activation by cell-bound furin.
After the activation of PA83, the remaining 63 kilo Dalton PA63
forms an oligomeric channel responsible for the binding and
translocation of EF and/or LF into the cytosol of target cells
[8,9,10,11,12].
Clostridium botulinum, well known for the production of potent
neurotoxins, produces various protein toxins, such as the AB type
C2 toxin [13,14,15]. The binding component of C2 toxin, C2II
(60 kilo Dalton after proteolytic cleavage with trypsin), forms
heptamers that insert into biological and artificial membranes at
an acidic pH and promotes the translocation of the 45 kilo Dalton
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enzymatic component C2I into the cytosol of the target cells upon
receptor-mediated endocytosis of the complex [16,17]. C2I acts as
an ADP-ribosyltransferase on monomeric G-actin, causing
disruption of the actin cytoskeleton [18,19].
The enzymatic components of anthrax and C2 toxin differ
significantly in their enzymatic activity and do not show any
homology in their primary structures. However, the binding
components PA and C2II share a considerable sequence
homology of about 35% in two of three domains, indicating that
they are closely related in structure and hence also in function
[3,8,20,21]. In recent years, many important structural features,
particularly concerning PA, have been unveiled, such as the W-
clamp and the loop network responsible for allocation of the PA
monomers [22,23]. Interesting details concerning the possible
mode of translocation are known, all favoring an acid-induced
disassembly of the enzymatic components to a molten globular
state, followed by threading of the N-terminal part of the
polypeptide chain through the pore [22,23,24,25]. However, the
exact mode of transporting the enzymatic components into the
cytosol of target cell is still not fully solved. The first crucial step of
the translocation mechanism is the binding of the enzymatic
components to the receptor-bound prepore on the cell surface [1].
Previous results of our and other groups evidenced that truncated
forms of the enzymatic components as well as full size EF and LF
block the pores formed by PA63, and that an N-terminal His6-tag
strengthens their affinity [20,26,27]. Binding of the N-terminal
ends of EF and LF to PA63 is followed by endocytosis, acidification
of the endosomes and finally release of the enzymatic components
into the cytosol of target cells, where they exert their fatal
enzymatic activities [9,10,28]. Interestingly, LF’s amino-terminal
part, LFN (LF1-254), is sufficient to confer the ability to associate
with PA63 pores. It can even be used to drive the translocation of
unrelated polypeptides into target cells via PA63 or C2II [29,30].
To further elucidate the mode of binary toxins’ translocation
into target cells and the possible cross-reactivity of the different
enzymatic components via the homologous binding component of
the other toxin; we performed in vitro and in vivo (i.e. cell-based
assay) experiments interchanging the different A-B components of
anthrax and C2 toxin. Most importantly our data show the high
capacity of PA63 to bind C2I in vitro in the black lipid bilayer assay.
Complementary to these findings we evidence the functionality of
PA/C2I chimera toxin combination in cell intoxication. Further,
C2II appeared more specifically involved in C2I binding and
translocation. Together, our data unveiled the remarkable ability
of PA to support cell intoxication by C2I, a distantly related AB7/8
toxin component.
Materials and Methods
Materials
PA, LF and EF genes were PCR-amplified from genomic DNA
of Bacillus anthracis strain Sterne (a kind gift of Patrice Boquet, Nice,
France) and cloned into the pQE30 (Qiagen), pET28a and
pET22b (Novagen) expression plasmids, respectively. The N-
terminal His6-tag was removed from His6-EF by incubation with
thrombin and from His6-LF with enteropeptidase, respectively.
Nicked anthrax PA63 from B. anthracis was obtained from List
Biological Laboratories Inc., Campbell, CA. One mg of
lyophilized protein was dissolved in 1 ml 5 mM HEPES,
50 mM NaCl, pH 7.5 complemented with 1.25% trehalose.
Aliquots were stored at 220uC. Channel formation by PA63 was
stable for months under these conditions. C2I and C2II genes
were PCR-amplified from genomic DNA of Clostridium botulinum D
strain 1873 and cloned into pET22 (Novagen) and pQE30
(Qiagen) expression plasmids. All genes were cloned with BamHI-
SacI restriction sites. Recombinant toxins containing His6-tags
were expressed in Escherichia. coli BL21 (DE3) and purified on a
Chelating Sepharose Fast Flow column previously chelated with
nickel (Amersham Biosciences) as recommended by the manufac-
turer and described previously [5]. Fractions containing toxin were
pooled and dialyzed over night against 250 mM NaCl and 25 mM
Tris-HCl, pH 8. Recombinant C2II and C2I proteins used for
bilayer measurements were cloned in pGEX-2T vector in E. coli
BL21 cells and expressed as glutathione S-transferase (GST) fusion
proteins with the glutathione S-transferase-fusion Gene Fusion
System from Amersham Pharmacia Biotech [17,18]. The proteins
were purified as described previously [18] and incubated with
thrombin (3.25 NIH units/ml bead suspension) for cleavage of the
GST-tag [31]. C2II was activated with 0.2 mg of trypsin per
microgram of protein for 30 min at 37uC [31].
Western Blots
The polyclonal antibodies against the N-terminal part of MEK2
(N20) were purchased from Santa Cruz Biotechnology; monoclo-
nal antibodies against ß-actin were obtained from Sigma-Aldrich
(clone AC-74). Primary antibodies were visualized using goat anti-
mouse or anti-rabbit horseradish peroxidase-conjugated secondary
antibodies (DakoCytomation), followed by chemiluminiscence
detection ECL (GE Healthcare).
Cell culture
Human umbilical vein endothelial cells (HUVECs, a human
primary cell line obtained from PromoCell) were grown in serum-
free medium (SFM) supplemented with 20% FBS (Invitrogen),
20 ng/ml basic ßFGF (Invitrogen), 10 ng/ml EGF (Invitrogen)
and 1 mg/ml heparin (Sigma-Aldrich) as described previously [32].
Adenylate cyclase activity
Intracellular concentration of cyclic AMP (cAMP) was deter-
mined using the Cyclic AMP Assay (R&D Systems).
ADP-ribosylation
Control cells or intoxicated HUVECs (105 cells/conditions)
were homogenized in 0.25 ml cold BSI buffer (3 mM imidazole
pH 7.4, 250 mM sucrose) supplemented additionally with 1 mM
phenylmethylsulfonyl fluoride. Cells were lysed by passing through
a 1 ml syringe equipped with a 25G65/8’’-needle (U-100 Insulin,
Terumo) 40 times. Nuclei were removed by centrifugation for 10
minutes at 4uC. Protein concentrations of the post-nuclear
supernatants were determined using Dc protein assay (Bio-Rad).
ADP-ribosylation was performed for 90 minutes at 37uC on 5 mg
of intoxicated cell lysates, supplemented with 0.5 mCi [32P]-NAD
(800 Ci/mmol) and 1 mg of C2I. Proteins were resolved on 12%
SDS-PAGE and in vitro ADP-ribosylated actin was revealed using a
phosphorimaging system.
Lipid bilayer experiments
Black lipid bilayer measurements were performed as described
previously [33]. The instrumentation consisted of a Teflon
chamber with two aqueous compartments connected by a small
circular hole. The hole had a surface area of about 0.4 mm2.
Membranes were formed by painting a 1% solution of diphytanoyl
phosphatidylcholine (Avanti Polar Lipids, Alabaster, AL) in n-
decane onto the hole. The aqueous salt solutions (Merck,
Darmstadt, Germany) were buffered with 10 mM MES to
pH 5.5 to pH 6. Control experiments revealed that the pH was
stable during the time course of the experiments. The binding
Cross-Reactivity of Anthrax and C2-Toxin
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components of the binary toxins were reconstituted into the lipid
bilayer membranes by adding concentrated solutions to the
aqueous phase to one side (the cis-side) of a black membrane.
The temperature was kept at 20uC throughout. Membrane
conductance was measured after application of a fixed membrane
potential with a pair of silver/silver chloride electrodes inserted
into the aqueous solutions on both sides of the membrane.
Membrane current was measured using a homemade current-to-
voltage converter made with a Burr Brown operational amplifier.
The amplified signal was monitored on a storage oscilloscope and
recorded on a strip chart recorder.
Binding experiments
The binding of EF and LF to the C2II channel and the binding
of C2I to the PA63 and to the C2II channel was investigated
performing titration experiments similar to those used previously
to study the binding of 4-aminoquinolones to the PA63 and C2II
channels and LF to the PA63 channel in single- or multi-channel
experiments [34,35,36]. The PA63 and C2II channels were
reconstituted into lipid bilayers. About 60 minutes after the
addition of either activated PA63 or C2II to the cis-side of the
membrane, the rate of channel insertion in the membranes was
very small. Then concentrated solutions of EF, LF or C2I were
added to the cis-side of the membranes while stirring to allow
equilibration. The results of the titration experiments, i.e. the
blockage of the channels, were analyzed using Langmuir
adsorption isotherms (see eqn. [1]) [20,37].
G cð Þ~Gmax
1
K :cz1ð Þ ð1Þ
G(c) is the conductance of the channels at a given concentration
c of the enzymatic components and Gmax is their conductance
Figure 1. Interaction of C2I with PA63 channels. A: Titration of PA63 induced membrane conductance with C2I. The membrane was formed from
diphytanoyl phosphatidylcholine/n-decane, containing about 5,500 channels. C2I was added at the concentrations shown at the top of the panel.
Finally, about 40% of the PA63 channels were blocked. The aqueous phase contained 1 ng/ml activated PA63 protein (added only to the cis-side of the
membrane), 150 mM KCl, 10 mM MES pH 6. The temperature was 20uC and the applied voltage was 20 mV. Note that C2I only blocks PA63 channels
when it is added to the cis-side of the membrane (data not shown). B: Lineweaver-Burke plot of the inhibition of the PA63-induced membrane
conductance by C2I. The fit was obtained by linear regression of the data points taken from Figure 1A (r2 = 0.996654) and corresponds to a stability
constant K for C2I binding to PA63 of (3.9860.063) 610
6 M21 for C2I binding to PA63 (half saturation constant KS = 251 nM).
doi:10.1371/journal.pone.0023133.g001
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before the start of the titration experiment (at c = 0). K is the
stability constant for binding of the enzymatic components of the
binary toxins to the PA63 or C2II channels. The half saturation
constant Ks of binding is given by the inverse stability constant 1/
K. The percentage of blocked channels is given by:
% closed channels ~
100:K:c
K :cz1
ð2Þ
Statistics
Unpaired, two-sided Student’s t-test was used to analyze
biological data with * p,0.05. The statistical software used was
Prism 5.0b. The fit of the data from the titration experiments with
lipid bilayers was performed using the scientific data graphics
application program Fig.P. For most of the fits of the titration data
with eqn. [2] we obtained r2 .0.99.
Results
Interaction of PA63 with C2I in vitro
The stability constant K for the binding of C2I to the PA63
channel was measured in multi-channel experiments, performed
as described previously [35]. About 60 minutes after addition of
the protein, the rate of conductance increase had slowed down
considerably. At that time, small amounts of a concentrated
enzyme solution were added to the cis-side of the membrane and
the PA63-induced membrane conductance decreased in a dose-
dependent manner. Figure 1A shows an example for a titration
experiment with an applied voltage of 20 mV in 150 mM KCl in
which increasing concentrations of C2I (arrows) were added to the
cis-side of a membrane containing about 5,500 PA63 channels. The
membrane conductance decreased as a function of the C2I
concentration within a few minutes after addition of C2I (see
figure 1A). The data of Figure 1A and of similar experiments were
analyzed using equation [2] as described previously [35,38]. The
plots of the percentage of closed channels as a function of the
enzyme concentrations were used to calculate the stability
constants K for binding as it is shown in Figure 1B for the data
of Figure 1A. The fit curve (solid line in Figure 1A) corresponds to
a stability constant K of (3.9860.063) 6106 M21 for C2I binding
to PA63 (half saturation constant KS = 251 nM). The stability
constant K of the binding of C2I to the PA63 channels was
averaged out of at least five individual experiments resulting in K
(5.161.5) 6106 M21 (half-saturation constant Ks = 196 nM) (see
Table 1). Measurements with artificial bilayer membranes of the
wild-type AB components C2II and C2I revealed a stability
constant K of (3.760.4) 6107 M21 with a half saturation constant
KS of 27.2 nM.
Binding of C2II with EF and LF in vitro
As demonstrated in recent studies, EF and LF of anthrax toxin
are able to block the PA63 pore in artificial bilayer membranes at
nanomolar concentrations [20] and C2II channels can be blocked
by their enzymatic counterpart C2I [18]. The possible binding of
EF and LF to the C2II channels was studied using titration
experiments as described above for PA63 and C2I shown in
Figure 1. These measurements allowed the calculation of the
stability constants K of EF and LF binding to the C2II channels,
resulting in (7.764.8) 6107 M21 and (2.060.3) 6107 M21,
respectively (see Table 1). The data indicated that EF and LF
have a high affinity for the C2II channels in vitro, as the half
saturation constants KS for EF and LF binding to the C2II
channels were 13.0 nM and 49.9 nM, respectively.
PA63 translocates C2I in HUVECs
C2I acts as an ADP-ribosyltransferase targeting cellular G-actin.
Therefore, successful delivery of this enzymatic component into
target cells can be detected by disruption of the cytoskeleton
followed by rounding up of target cells and detachment of target
cells from the extracellular matrix, defined as intoxicated cells [18]
or by direct measurement of the modified G-actin as described in
Materials and Methods. C2I, added to different concentrations of its
native binding component C2II, led to increasing numbers of
round cells after 24 hours of intoxication (data not shown).
Figure 2A shows the direct measurement of cellular ADP-
ribosylated actin (ADPr-actin) in HUVECs after treatment with
different PA-C2I and C2II-C2I combinations. The cells were
intoxicated with different concentrations of binding components
and effectors as indicated. Levels of ADP-ribosylated actin (ADPr-
actin) were determined by in vitro ADP-ribosylation of cell lysates
with C2I and radiolabeled [32P]-NAD. Under these conditions
ADP-ribosylated actin produced by the intoxication process is no
longer labeled by in vitro ADP-ribosylation. The results clearly
demonstrated that the radioactivity combined with labeled ADPr-
actin decreased for the combinations PA-C2I, when PA was
applied in high concentration, and C2II-C2I suggesting that both
channels were able to transport C2I into HUVECs. Controls did
not reveal any change of the labeling of actin, which means that
neither PA nor C2I alone, respectively, modified intracellular actin
(data not shown).
Similar results were obtained when the number of intoxicated
HUVECs was determined by counting round cells as a result of
C2I activity on actin. Figure 2B shows the efficiency of cell
intoxication under different experimental conditions. HUVECs
were incubated with different combinations of PA-C2I and C2II-
C2I as indicated, and the number of intoxicated cells was directly
assessed. The results shown in Figure 2B revealed that the number
of intoxicated cells was highest for the native combination C2II-
C2I. However, when HUVECs were incubated with C2I and
different quantities of PA, rounding of cells was detected even at
Table 1. Stability constants K and half saturation constants KS
for the cross-reaction of anthrax and C2 toxin.
Toxin combination K [M21] Ks [nM]
PA with
C2I (0.5160.15) 6107 196
EF 14.56107 6.9
LF 36.26107 2.8
C2II with
EF (7.764.8) 6107 13.0
LF (2.060.3) 6107 49.9
C2I (3.760.4) 6107 27.2
bility constants K for the binding of C2I, EF or LF to PA63 or C2II channels
reconstituted in lipid bilayer membranes. The membranes were formed from
diphytanoyl phosphatidylcholine/n-decane. The aqueous phase contained
150 mM KCl, buffered to pH 5.5 to 6 using 10 mM MES-KOH; T = 20uC.
Measurements were performed at a membrane potential of 20 mV. The data
represent the means of at least three individual titration experiments. KS is the
half saturation constant, i.e. 1/K. Some of the wild-type toxin combinations
(given in bold) were taken from reference [20].
doi:10.1371/journal.pone.0023133.t001
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lower probability (Figure 2B). This demonstrated that C2I was
transported by PA channels into HUVECs. The results of
Figure 2B indicated a dose-dependent process as some combina-
tions failed to induce any significant effect compared to the
controls.
Interaction of C2II with LF and EF in vivo (cell-based
assay)
The enzymatic activity of the lethal factor (LF) of anthrax toxin
can be measured by monitoring the cleavage of MAPKK, e.g. with
MEK2 amino-terminal antibodies (anti-MEK2) [4]. HUVEC
monolayers were intoxicated overnight with different combina-
tions of PA-LF or C2II-LF and the activity of LF was analyzed on
cell lysates by anti-MEK2 immunoblotting. Control experiments
were performed in the absence of binding components. Whereas
the wild-type lethal toxin (PA-LF) did not give any MEK2 signal
after blotting, the combination of LF with different quantities of
C2II revealed a defined signal of intact MEK2 (Figure 3A).
Considering our findings that C2II mediated an efficient
translocation of C2I into cells under these conditions (Figure 2A
and 2B) we can present evidence that C2II has a dramatically
lower capacity to promote translocation of LF into target cells.
Anthrax edema factor (EF) is known to increase cAMP in target
cells when applied with its native binding partner PA63 [39]. We
next tested whether C2II is able to promote translocation of EF by
measure of the intracellular concentration of cAMP after
overnight incubation of HUVEC monolayers. The combination
of PA with EF led to a significant increase of intracellular cAMP
level as a function of PA concentration. In contrast, the application
of C2II-EF did not increase cAMP cellular levels significantly
(Figure 3B). Even at very high concentration of C2II (30 mg/ml)
the cellular cAMP level was approximately similar as the control
and considerably below the effect of 0.03 mg/ml PA combined
with 1 mg/ml EF. This means that translocation of EF by C2II is
at least 1000-fold less efficient than PA when the same
concentrations of PA and C2II were compared.
We next verified that addition of EF was able to compete with
C2I binding to C2II. The results are summarized in Figure 4. At a
concentration of 50 mg/ml EF could significantly block C2II-
mediated transport of C2I into HUVECs. These data further
Figure 2. Specificity of HUVECs intoxication by C2I using PA63 in comparison to C2II. HUVECs (5610
5 cells/100 mm well) were intoxicated
with the indicated concentration of polypeptides during 48 (A) or 24 hours (B). A: Cells were intoxicated as indicated and levels of cellular ADP-
ribosylated actin (ADPr-actin) were determined by in vitro ADP-ribosylation of cell lysates with C2I and radiolabeled [32P]-NAD. Under these
conditions ADP-ribosylated actin formed during the intoxication process is no longer labeled by in vitro ADP-ribosylation, which is indicated by
decrease of radioactivity. Immunoblotting anti-beta-actin was performed in parallel on cell lysates to show actin protein levels engaged in the ADP-
ribosylation experiments. ADP-ribosylation signals were normalized to actin immunoblot signals. B: Efficiency of cell intoxication. Cells were
intoxicated and the number of round cells was directly assessed by counting floating cells. The columns show mean values of 5 independent
counting for the individual conditions 6 SEM (ns: non significant; * p,0.05 versus control).
doi:10.1371/journal.pone.0023133.g002
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suggest that EF binds to the C2II channel in vivo (cell-based assay).
Together, these findings show that C2II does not promote cell
intoxication by EF and LF efficiently.
Discussion
In previous studies we already demonstrated that the enzymatic
components EF and LF of anthrax toxin bind to their B
component protective antigen (PA63) and C2I of C2 toxin binds
to its B component C2II in vitro [18,20,34]. PA shares significant
sequence homology (35%) with C2II, indicating that the two
proteins have similar modes of action. PA63 has been crystallized
in its monomeric and heptameric prepore form [8] and a model of
the C2II prepore structure has been constructed based on the
corresponding assembly of the protective antigen prepore [21].
The similarity of both structures supports the view of a common
mode of action, including the assumption that the enzymes bind in
the vestibule of the channels of the corresponding binding
component.
The results presented here suggest an interesting cross-over
reactivity of anthrax and C2 toxins, despite a completely different
primary and 3D-structure of the enzymatic compounds EF, LF
and C2I [40,41,42]. The stability constants K for binding in the
cross-over experiments in vitro were generally smaller than those
for the native combinations, except the combination of C2II-EF.
However, EF, LF and C2I show a high stability constant K for
binding to PA63 and C2II heptamers in the cross-over experiments
as the half saturation constants Ks are between 2 and about
200 nM (see Table 1). These results refer to a common
mechanisms and binding motifs within the enzymes’ primary
structures, in particular within the first three hundred amino acids
of EF, LF and C2I. Truncated forms of EF and LF, called EFN
and LFN, bind with high affinity to the PA63 channels and support
the transport of other polypeptides into target cells [26,30,43,44],
although the binding affinity of EFN and LFN for the PA63 channel
is substantially reduced as compared to wild-type EF and LF [45].
Similarly, the N-terminal part of C2I is sufficient for transport of
truncated forms of C2I and chimera proteins between the N-
terminal end of C2I and other proteins into target cells [46,47].
This means that the N-terminal ends of all enzymatic compounds
interact with the PA63 and the C2II pores. Some of the amino
acids responsible for these interactions are well known within the
primary sequence of PA63 and its water-soluble prepore, e.g.
amino acids E398, D425 and F427 (also known as the W-clamp)
[22,48,49], but relatively unknown for C2II, although there exist
some indications that the corresponding amino acids E399, D426
Figure 3. HUVECs intoxication by EF and LF using C2II in comparison to PA. All intoxication experiments were performed on HUVEC
monolayers. Cells were treated overnight with either 1 mg/ml of LF or EF in the presence or absence of different amounts of PA or C2II, as indicated.
A: Immunoblot anti-MEK2 showing the effect of MEK2 proteolysis by LF. 30 mg of total protein lysate were resolved on 12% SDS-PAGE. Anti-beta-
actin immunoblot shows protein loading. MEK2 signals were normalized to actin. B: Graph shows measure of cyclic AMP (cAMP) cellular
concentrations, expressed as pmol/ml. Mean values of two independent experiments 6 SEM (ns: non significant and * p,0.05).
doi:10.1371/journal.pone.0023133.g003
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and F428 may play a similar role for C2I binding [50]. However,
further amino acids responsible for this interaction still need to be
identified.
The amino acids responsible for binding within the N-terminal
end of the enzymatic components are relatively unknown,
although there is clear evidence that positively charged amino
acids are involved as they form salt bridges between the enzymatic
components and the channels. The positively charged N-termini of
the enzymes is presumably decisive as quaternary ammonium ions
and 4-aminoquinolones show a blockage of PA63 and C2II
channels in lipid bilayer experiments [34,36,51,52]. The selectivity
of the two channels for cations, which is at least partially due to the
charged amino acids in the b-barrel, may also play a significant
role. Both channels are known to prefer cations over anions in
zero-current membrane-potentials, the Pcation over Panion, as
described by the Goldman-Hodgkin-Katz equation [53], are 20
for PA63 channels and 10 for C2II channels, respectively [54,55].
Therefore cations have a strong effect on the single channel
conductance as compared to anions [54,55]. It may be possible
that the differently charged channel interiors of PA and C2II have
a decisive influence on binding and transport of the enzymatic
components (see below). Altogether there exist strong indications
that binding to the different channels follows different mecha-
nisms.
Another conceivable possibility is that the structure of the
channel itself is important for translocation. The extended
channel-forming b-sheets of the PA63 monomers contain three
glutamic acids and three aspartic acids (E302, E308, E343 and
D276, D315, D335), so the extended b-barrel could contain up to
48 negatively charged groups, which probably cannot be
counterbalanced by the at least partially positively charged
histidines H304 and H310 [56,57,58]. However, the C2II channel
contains 7 glutamic acids (E307) and 14 histidines (H296 and
H332), indicating that it has a much smaller overall charge [31].
The interaction of the charged groups of the channel interior and
the bound enzymatic components could be different for channels
leading to divergent uptake efficiency. Considering the fact that
the charges in the vestibule domain are quite balanced in both
PA63 and C2II, i.e. both have 14 acidic amino acids facing the
interior of the vestibule domain; the effect of the charges in the
water filled b-barrels should be striking. As mentioned beforehand,
the C2II channel is missing most of them.
The most interesting result of this study was that the
combination of PA with C2I showed HUVEC toxicity. This
appeared specific of PA considering the rather poor capacity of
C2I to bind and to trigger cell intoxication by LF. This clearly
reveals that PA has the remarkable ability to bind and to
translocate an enzymatic component of another AB7/8 type toxin
into cells. The level of cell intoxication with C2I via PA, however,
was at least 50-fold less efficient than with the wild-type
combination C2II-C2I. We can only speculate about the reasons
of this higher flexibility of PA as compared to C2II. One possibility
is that a different driving force is required to translocate EF and LF
through the C2II channel because EF and LF are released at the
state of the late endosome [9], whereas C2I leaves the early
endosome following acidification and, in addition, depends on the
help of the cytosolic chaperon Hsp90 [16,59]. A similar
requirement is not known for the translocation of LF, EF or
LF’s N-terminal domain (LFN) through the PA63 channel, where a
pH-gradient across the membrane creates a sufficient driving force
for translocation of the proteins [24]. With the evidence presented
here, i.e. that some components of the highly specialized binary
toxins can be interchanged without loss of toxicity, further work
with mutated binding components, enzymatic moieties and
chimeras seems to be necessary to understand the different
translocation capacities of PA63 and C2II channels.
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